Riboflavin requirements for total parenteral nutrition (TPN) regimens have not been adequately determined. We investigated the riboflavin status of low-birthweight infants maintained by TPN formulation which provided 4 mg/day of riboflavin to each infant compared to that of infants fed orally on formula containing 1.0 to 5.0 mg riboflavin/liter.15 newborn infants (birthweight 570-2350 grams) had baseline blood samples drawn prior to TPN or formula feeding. The patients had second blood samples drawn after they had been fed either orally (n=7) or by TPN (n=8) for at least 7 days.None of the 15 infants showed abnormal riboflavin status and the range established for these low-birthweight infants (AC 0.86-1.19) corresponds to that established for healthy full-term newborns(0.9-1.2). (Proc. Soc. Exp. Biol. Med 143:326, 1973).From this pilot study, it appears that 4 mg/day of riboflavin provided to low-birthweight infants in a TPN solution maintains riboflavin status during the time period studied (7 days).
Read full abstract